GlassScriptPhysician profile
Stephen F Dobkin
NPI 1306899893
$9,102.84
in general payments reported to CMS, 2019-2025
34 companies · $2,595 in 2025
The $2,595 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $1,129 · 2021: $1,141 · 2022: $1,778 · 2023: $949 · 2024: $847 · 2025: $2,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,392.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,671.43 | 2019-2025 | Lithovue, Escape, Rezum Generator |
| Medtronic, INC. | $1,263.21 | 2021-2025 | Interstim, Altaviva |
| Teleflex LLC | $1,174.60 | 2021-2025 | Urolift, Barrigel |
| Calyxo, INC. | $1,023.91 | 2023-2025 | Cvac Aspiration System |
| Medtronic USA, INC. | $617.80 | 2020 | |
| Procept Biorobotics Corporation | $477.50 | 2024-2025 | Aquabeam System |
| Coloplast Corp | $453.70 | 2019-2023 | Speedicath |
| Janssen Biotech, INC. | $453.48 | 2020-2025 | Rybrevant, Carvykti, Erleada |
| Neotract INC. | $369.52 | 2019-2020 | |
| Axonics, INC. | $325.24 | 2022-2023 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $263.13 | 2021-2023 | Aveed, Xiaflex |
| Karl Storz Endoscopy-America | $165.71 | 2021 | |
| Abbvie INC. | $106.32 | 2022-2023 | Lupron Depot, Botox |
| Pfizer INC. | $85.62 | 2021-2023 | |
| Astellas Pharma US INC | $75.84 | 2022-2023 | Myrbetriq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $70.41 | 2023 | Orgovyx |
| Janssen Scientific Affairs, LLC | $59.57 | 2025 | Erleada, Pipeline |
| Merck Sharp & Dohme LLC | $48.57 | 2023 | Keytruda, Lynparza, Welireg |
| Dentsply Ih Ab | $41.23 | 2023-2025 | Lofric, Lofric |
| Integra Lifesciences Corporation | $38.24 | 2022 | |
| Antares Pharma, INC. | $37.50 | 2021-2022 | |
| Urogen Pharma, INC. | $33.75 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $31.34 | 2022 | |
| Blue Earth Diagnostics | $29.58 | 2022 | |
| Stryker Corporation | $28.64 | 2022 | |
| 180 Medical, INC. | $27.35 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $21.13 | 2022 | |
| Ambu INC. | $20.27 | 2023 | |
| Accord Healthcare, INC. | $17.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.42 | 2023 | |
| Smith+Nephew, INC. | $16.34 | 2019 | |
| Allergan, INC. | $13.49 | 2019 | |
| Lumenis, INC | $12.44 | 2021 | |
| Clarus Therapeutics INC. | $10.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dobkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.